vMIP (Jinan University)

重组病毒巨噬细胞炎性蛋白（暨南大学）

Report date: 2022/06/27 20:00:35

Base Information

Drug NamevMIP (Jinan University)
Drug Alias Namerecombinant viral macrophage inflammatory protein注射用重组病毒巨噬细胞炎性蛋白（vMIP）
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonistsC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5C-X-C motif chemokine receptor 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesJinan University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesJinan University
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A